Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Achilles Allograft With or Without InternalBrace for ACL Revision Surgery (ACL-AlloRev)

4 mai 2026 mis à jour par: Medical University of Graz

Achilles Tendon Allografts With and Without InternalBrace Augmentation for Anterior Cruciate Ligament Revision Surgery: A Randomized Controlled Pilot Trial

This study evaluated outcomes after revision anterior cruciate ligament reconstruction using Achilles tendon allografts with a calcaneal bone block, with or without additional InternalBrace augmentation. Revision ACL reconstruction is often more complex than primary ACL reconstruction because previous surgery may leave widened bone tunnels or bone defects. Achilles tendon allografts with attached bone blocks may help address these defects and allow reconstruction in a single surgical procedure.

Participants with MRI-confirmed ACL graft re-tear and clinical knee instability were randomized to undergo revision ACL reconstruction either with InternalBrace augmentation or without InternalBrace augmentation. Clinical outcomes, patient-reported knee function, health-related quality of life, and MRI findings were assessed during 13 months of follow-up. The study was designed as a prospective randomized controlled pilot trial to compare whether additional InternalBrace augmentation improved functional, radiographic, or quality-of-life outcomes after revision ACL surgery.

Aperçu de l'étude

Description détaillée

Anterior cruciate ligament revision surgery remains challenging and may have less predictable outcomes than primary ACL reconstruction. In revision cases, prior bone tunnels and bone defects can complicate graft fixation. Achilles tendon allografts with calcaneal bone blocks provide a reliable graft configuration and may help fill pre-existing bone defects during a one-stage revision procedure. InternalBrace augmentation is intended to provide additional support to the reconstructed ligament during the healing period, but clinical evidence for its use with allograft ACL revision surgery is limited.

This prospective, randomized controlled pilot study enrolled patients from February 2017 to September 2020 at the Medical University of Graz. Eligible participants had MRI-confirmed re-tear of the ACL graft and clinical and patient-reported knee instability. Patients with advanced associated lesions requiring reconstruction or prolonged restricted weight bearing, signs of infection, advanced osteoarthritis, or neuromuscular disease were excluded. For all included participants, the procedure was the first revision surgery on the affected knee. The study was approved by the Ethics Committee of the Medical University of Graz, and written informed consent was obtained before participation.

All participants underwent revision ACL reconstruction using an Achilles tendon allograft with a calcaneal bone block. Participants were randomized in a 1:1 ratio to receive either additional InternalBrace augmentation or no InternalBrace augmentation. The InternalBrace group received a non-resorbable polyethylene FiberTape fixed separately and independently from the ACL graft. Apart from the additional InternalBrace fixation in one group, the surgical technique and postoperative rehabilitation protocol were the same for all participants.

Clinical and patient-reported outcomes were assessed preoperatively and at 6 weeks, 12 weeks, 6 months, and 13 months after surgery. Outcome measures included the International Knee Documentation Committee score, Lysholm Knee Questionnaire, Tegner Activity Scale, Knee Injury and Osteoarthritis Outcome Score, and Short Form-36. MRI scans were performed before surgery and 13 months after surgery to assess graft appearance, graft tightness, graft signal, ligament signs at the femoral and tibial tunnel insertions, and tunnel size.

The final analyzed study population included 30 participants, with 16 participants in the InternalBrace group and 14 participants in the non-InternalBrace group. Overall, clinical and patient-reported outcomes improved during follow-up. At the final 13-month follow-up, there were no clinically relevant differences between the InternalBrace and non-InternalBrace groups. Postoperative MRI showed elongated or insufficient ACL allografts in 15 of 30 participants, without significant differences between groups. The study concluded that ACL revision surgery using Achilles tendon allografts with bone blocks resulted in improved clinical outcomes at 13 months, but additional InternalBrace augmentation did not improve objective or subjective outcomes in this pilot trial.

Type d'étude

Interventionnel

Inscription (Réel)

32

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Styria
      • Graz, Styria, L'Autriche, 8036
        • Medical University of Graz

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • MRI-confirmed re-tear of the anterior cruciate ligament.
  • Clinical knee instability.
  • Patient-reported knee instability.
  • Planned first revision anterior cruciate ligament reconstruction of the affected knee.
  • Ability to undergo the standardized postoperative rehabilitation protocol.
  • Written informed consent for study participation and use of study data.

Exclusion Criteria:

  • Advanced associated knee lesions, such as pronounced meniscal tears or cartilage defects, requiring reconstruction or prolonged reduced weight bearing.
  • Signs of infection.
  • Advanced-stage osteoarthritis.
  • Neuromuscular disease.
  • Previous revision surgery on the affected knee.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: InternalBrace Augmentation
Participants underwent revision anterior cruciate ligament reconstruction using an Achilles tendon allograft with calcaneal bone block and additional InternalBrace augmentation. The InternalBrace consisted of non-resorbable polyethylene FiberTape fixed separately and independently from the ACL allograft.
Revision anterior cruciate ligament reconstruction was performed using an Achilles tendon allograft with calcaneal bone block. In this group, a non-resorbable polyethylene FiberTape InternalBrace was additionally fixed separately and independently from the ACL allograft to support the graft during healing.
Autres noms:
  • Revision ACL Reconstruction With InternalBrace
  • ACL Revision Surgery With InternalBrace Augmentation
  • Achilles Tendon Allograft ACL Revision With Suture Tape Augmentation
Comparateur actif: No InternalBrace Augmentation
Participants underwent revision anterior cruciate ligament reconstruction using an Achilles tendon allograft with calcaneal bone block without additional InternalBrace augmentation. Apart from the InternalBrace augmentation, the surgical technique and postoperative rehabilitation protocol were the same as in the InternalBrace group.
Revision anterior cruciate ligament reconstruction was performed using an Achilles tendon allograft with calcaneal bone block. No additional InternalBrace or suture tape augmentation was used. Apart from the absence of InternalBrace augmentation, the surgical technique and postoperative rehabilitation protocol were the same as in the InternalBrace augmentation group.
Autres noms:
  • Revision ACL Reconstruction Without InternalBrace
  • ACL Revision Surgery Without InternalBrace Augmentation
  • Achilles Tendon Allograft ACL Revision Without Suture Tape Augmentation

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
International Knee Documentation Committee Score
Délai: Preoperative baseline to 13 months after surgery
The International Knee Documentation Committee score was used to assess patient-reported knee symptoms, function, and sports activity after revision anterior cruciate ligament reconstruction. Scores range from 0 to 100, with higher scores indicating better knee function.
Preoperative baseline to 13 months after surgery

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Lysholm Knee Questionnaire Score
Délai: Preoperative baseline to 13 months after surgery
The Lysholm Knee Questionnaire was used to assess knee symptoms and functional limitations after revision anterior cruciate ligament reconstruction. Scores range from 0 to 100, with higher scores indicating better knee function.
Preoperative baseline to 13 months after surgery
Tegner Activity Scale Score
Délai: Preoperative baseline to 13 months after surgery
The Tegner Activity Scale was used to assess participant activity level after revision anterior cruciate ligament reconstruction. Scores range from 0 to 10, with higher scores indicating a higher activity level.
Preoperative baseline to 13 months after surgery
Knee Injury and Osteoarthritis Outcome Score
Délai: Preoperative baseline to 13 months after surgery
The Knee Injury and Osteoarthritis Outcome Score was used to assess knee-related pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life. Subscale scores range from 0 to 100, with higher scores indicating better outcomes.
Preoperative baseline to 13 months after surgery
MRI Assessment of ACL Allograft Tightness
Délai: 13 months after surgery
Postoperative magnetic resonance imaging was used to assess anterior cruciate ligament allograft tightness. Grafts were categorized as tight, elongated, or insufficient.
13 months after surgery
MRI Assessment of Femoral and Tibial Tunnel Size
Délai: 13 months after surgery
Postoperative magnetic resonance imaging was used to measure femoral and tibial tunnel size after revision anterior cruciate ligament reconstruction. Tunnel size was measured in millimeters.
13 months after surgery
Short Form-36 Physical Component Summary Score
Délai: Preoperative baseline to 13 months after surgery
The Short Form-36 Physical Component Summary score was used to assess physical health-related quality of life after revision anterior cruciate ligament reconstruction. Scores range from 0 to 100, with higher scores indicating better physical health-related quality of life.
Preoperative baseline to 13 months after surgery
Short Form-36 Mental Component Summary Score
Délai: Preoperative baseline to 13 months after surgery
The Short Form-36 Mental Component Summary score was used to assess mental health-related quality of life after revision anterior cruciate ligament reconstruction. Scores range from 0 to 100, with higher scores indicating better mental health-related quality of life.
Preoperative baseline to 13 months after surgery

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Paul Ruckenstuhl, MD, Department of Orthopaedics and Trauma, Medical University of Graz

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 février 2017

Achèvement primaire (Réel)

30 septembre 2021

Achèvement de l'étude (Réel)

30 septembre 2021

Dates d'inscription aux études

Première soumission

27 avril 2026

Première soumission répondant aux critères de contrôle qualité

27 avril 2026

Première publication (Réel)

4 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

8 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

4 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

De-identified individual participant data underlying the results reported in the publication will be shared upon reasonable request. Shared data may include baseline characteristics, group allocation, clinical outcome scores, patient-reported outcome measures, health-related quality-of-life scores, and MRI assessment data.

Délai de partage IPD

Data will be available upon reasonable request after publication, with no predetermined end date.

Critères d'accès au partage IPD

Qualified researchers may request access by contacting the corresponding author. Requests will be reviewed based on scientific purpose, ethical approval where applicable, and compliance with applicable data protection requirements. Only de-identified data relevant to the approved request will be shared.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner